Affinity-Asset-Advisors

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
91
Total Value
976714470
Accession Number
0001999371-25-006074
Form Type
13F-HR
Manager Name
Affinity-Asset-Advisors
Data Enrichment
86% identified
78 identified13 unidentified

Holdings

91 positions
Manager:
Search and click to pin securities to the top
Page 1 of 5
SPDR S&P 500 ETF TRUST
Shares:400.0K
Value:$223.8M
464287655
Shares:300.0K
Value:$59.8M
Xenon Pharmaceuticals Inc.
Shares:1.3M
Value:$44.6M
Apogee Therapeutics, Inc.
Shares:1.2M
Value:$43.0M
78464A870
Shares:500.0K
Value:$40.5M
Verona Pharma plc
Shares:615.0K
Value:$39.0M
Arcellx, Inc.
Shares:530.0K
Value:$34.8M
Alkermes plc.
Shares:1.0M
Value:$33.0M
Nuvalent, Inc.
Shares:460.0K
Value:$32.6M
MADRIGAL PHARMACEUTICALS, INC.
Shares:80.0K
Value:$26.5M
Centessa Pharmaceuticals plc
Shares:1.5M
Value:$22.2M
AMGEN INC
Shares:70.0K
Value:$21.8M
TEVA PHARMACEUTICAL INDUSTRIES LTD
Shares:1.4M
Value:$21.5M
Travere Therapeutics, Inc.
Shares:1.1M
Value:$19.2M
ALNYLAM PHARMACEUTICALS, INC.
Shares:55.0K
Value:$14.9M
Wave Life Sciences Ltd.
Shares:1.8M
Value:$14.7M
682143AG7
Shares:
Value:$14.3M
Merus N.V.
Shares:322.0K
Value:$13.6M
Axsome Therapeutics, Inc.
Shares:100.0K
Value:$11.7M
48576UAA4
Shares:
Value:$11.6M